Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis
Open accessThe DOI matches its Crossref record; 312 of the 326 references it cites were found in a registry or an index; 153 of the 280 sources its claims cite were checked for support.
Abstract
Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy. Despite their widespread use, conventional two-dimensional monolayer cultures fail to reproduce these complexities, contributing to the poor translational predictability of many preclinical candidates. Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms. Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk. Advances in spheroid analysis now enable detailed evaluation of drug penetration, cellular migration, cytotoxic response, and molecular gradients using techniques such as optical and confocal imaging, large-particle flow cytometry, biochemical viability assays, and microfluidic integration. By combining physiological relevance with analytical accessibility, spheroid models support mechanistic studies of drug transport and efficacy under tumor-like conditions. Their adoption into routine preclinical workflows has the potential to improve translational accuracy while reducing reliance on animal models.
Overview
CoChat Summary
TL;DR
This review argues that 3D multicellular tumor spheroids better capture tumor microenvironment barriers than 2D monolayers and can be analyzed with imaging, flow cytometry, viability assays, and microfluidics. It synthesizes TME biology, spheroid features, and analytical strategies to improve preclinical drug testing.
Key findings
- Spheroids reproduce spatial gradients seen in solid tumors: proliferative outer rim, quiescent intermediate zone, and hypoxic/necrotic core; these gradients typically emerge when spheroids exceed ~500 μm in diameter, core pH ranges between 6.5 and 7.2, and growth plateaus at approximately 600–800 µm.
- Stromal and ECM incorporation increases drug resistance: breast tumor spheroids with higher fibroblast content showed decreased dextran diffusion and diminished doxorubicin cytotoxicity, while pancreatic triple co-cultures of tumor cells, fibroblasts, and endothelial cells demonstrated greater drug resistance than spheroids lacking either stromal component.
- Spheroid gene expression more closely resembles solid tumors than monolayers: in melanoma spheroids, over 100 transcripts were upregulated and approximately 70 downregulated compared with monolayers; a meta-analysis of NCI-60 monolayers versus clinical tumor samples found about 30% of ~7000 genes with altered expression.
- Analytical approaches include brightfield/confocal/electron/SHG microscopy, large-particle flow cytometry, FLIM-BrdU, and microfluidic systems; large-particle flow cytometry tracked fibroblast migration toward the spheroid core by day 5 and endothelial cell clustering near fibroblasts.
Methods
- Narrative review; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Synthesizes published literature on TME components, limitations of 2D and in vivo models, spheroid biology, and techniques for spheroid analysis.
- No primary experimental data or sample; findings are drawn from cited studies and illustrative examples.
Limitations
- The paper does not state limitations.
- Evident from the review format: no systematic search or quantitative synthesis is reported, so literature coverage and conclusions may be non-exhaustive.
- Evident from the text: many cited findings come from specific cell lines and tumor models, and the review does not systematically assess reproducibility or generalizability across all tumor types.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
92 Valid · 7 Not valid · 43 Not checked · 20 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“cells located in the intermediate zone are often senescent”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 5. Spheroids as a More Physiologically Relevant TME Model > 5.1. Internal Structure of Spheroids
What the sources say
- Not checked — no full text of the sourcecites [101] Benien P. Swami A. 3D tumor models: History, advances and future perspectives Future Oncol. 2014 10 1311 1327 10.2217/fon.13.274 24947267 source
- Disputedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 sourceExperimental — accuracy not yet measured
In the Introduction section “Spheroids as appropriate models for drug delivery” (page not available), the paper describes the layer between the necrotic core and proliferating outer rim as quiescent, not senescent. Quiescence and senescence are distinct cellular states; the cited passage does not support substituting one for the other. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [186] Solomon M.A. Lemera J. D’Souza G.G. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics J. Liposome Res. 2016 26 246 260 10.3109/08982104.2015.1105820 26780923 source
- Could not verifycites [187] McIntyre A. Patiar S. Wigfield S. Li J.L. Ledaki I. Turley H. Leek R. Snell C. Gatter K. Sly W.S. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy Clin. Cancer Res. 2012 18 3100 3111 10.1158/1078-0432.CCR-11-1877 22498007 PMC3367109 sourceExperimental — accuracy not yet measured
The Results section describes hypoxia, proliferation, apoptosis and necrosis in spheroids, but does not identify an intermediate zone or characterize its cells as senescent. Searches for senescence, quiescence and the intermediate zone found no passage addressing the claim; page numbers were not available in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 1. Introduction
What the sources say
- Supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 source
The Tumor Microenvironment section describes how the extracellular matrix and interstitial fluid pressure affect drug penetration, while acidity and hypoxia affect response to anticancer therapies. The Enhanced permeability and retention effect section explains that nanoparticles remain in tumors partly because of poor lymphatic drainage. Together, these passages support the broad claim, particularly for nanoparticle drug delivery. (LLM, conf=0.90)
- Supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 source
In “Studying tumor tissue penetration: Illustration and tools” (page unavailable), the paper says that tumor-microenvironment factors largely determine drug penetration and can limit drug distribution. In “Studying target binding at a cellular/molecular level: Illustration and tools” (page unavailable), it describes tumor macrophages and efflux transporters affecting drug accumulation; the penetration section also links immune-cell composition to immunotherapy efficacy. These passages support the broad claim about penetration, retention, and therapeutic response. (LLM, conf=0.88)
- Partly supportedcites [4] Goenka A. Khan F. Verma B. Sinha P. Dmello C.C. Jogalekar M.P. Gangadaran P. Ahn B.C. Tumor microenvironment signaling and therapeutics in cancer progression Cancer Commun. 2023 43 525 561 10.1002/cac2.12416 37005490 PMC10174093 sourceExperimental — accuracy not yet measured
In “TME-based cancer therapy” (page unavailable), the review says poor tumor vasculature protects the tumor core from therapeutics delivered through the bloodstream, supporting an effect on drug penetration. The same section describes microenvironmental factors altering treatment response and ECM-targeted agents localizing treatment in tumors, but it does not establish an effect on drug retention specifically. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Partly supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [2] Khan S.U. Fatima K. Aisha S. Malik F. Unveiling the mechanisms and challenges of cancer drug resistance Cell Commun. Signal. 2024 22 109 10.1186/s12964-023-01302-1 38347575 PMC10860306 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Not checked — no full text of the sourcecites [14] Friedrich J. Seidel C. Ebner R. Kunz-Schughart L.A. Spheroid-based drug screen: Considerations and practical approach Nat. Protoc. 2009 4 309 324 10.1038/nprot.2008.226 19214182 source
- Partly supportedcites [15] Vinci M. Gowan S. Boxall F. Patterson L. Zimmermann M. Court W. Lomas C. Mendiola M. Hardisson D. Eccles S.A. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation BMC Biol. 2012 10 29 10.1186/1741-7007-10-29 22439642 PMC3349530 sourceExperimental — accuracy not yet measured
The Background (page not available) says three-dimensional cultures better reflect tumor architecture and microenvironmental features. The Results (page not available) report that tumor cells were generally less drug-sensitive in three-dimensional culture, but offer reduced drug access and hypoxia-related effects as possible explanations rather than established resistance mechanisms. The Discussion (page not available) describes stromal-cell incorporation as a modification to spheroids, not a feature of spheroids generally. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [16] Hirschhaeuser F. Menne H. Dittfeld C. West J. Mueller-Klieser W. Kunz-Schughart L.A. Multicellular tumor spheroids: An underestimated tool is catching up again J. Biotechnol. 2010 148 3 15 10.1016/j.jbiotec.2010.01.012 20097238 source
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes MCTS as reproducing tumor-cell characteristics and the layered structure and gradients of tumors. Section 5.5 reports that stromal interactions can alter drug sensitivity and describes resistance mechanisms in spheroids. The paper also notes that spheroids can be made with other cell types, so the claim does not imply every spheroid includes stroma. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk.”
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
“These gradients typically emerge when spheroids exceed ~500 μm in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes large spheroids as having oxygen gradients and concentric cell layers: quiescent cells in the middle and highly proliferative cells at the outside. It also identifies oxygen deficiency as a cause of hypoxia. Page numbers are not provided in our copy. (LLM, conf=0.93)
- Supportedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 source
The section “Spheroids as appropriate models for drug delivery” describes oxygen and proliferation gradients, with a quiescent layer inside an outer rim of proliferating cells. The section “Challenge 1: Forming and maintaining spheroids of uniform size” also describes a hypoxic core. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [185] Groebe K. Mueller-Klieser W. Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters Eur. Biophys. J. 1991 19 169 181 10.1007/BF00196343 2029873 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
86 more claims · 55 with their cited sources checked
Create a free account to see all 162 claims and to verify the 7 references still open.
- It may state two separate claims as one. 63
- Probably not a substantial claim. 12
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Confocal microscopy has been widely used to evaluate penetration profiles and is also capable of providing quantitative insights [294,295].”
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“This surrounding landscape—referred to as the tumor microenvironment (TME)—comprises a complex network of cellular, acellular, and immune components [5,20,21].”
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915 · cited 1×
“Importantly, ECM composition is not static; it undergoes continuous remodeling through enzymatic degradation, de novo synthesis, and reorganization, all of which are tightly regulated by the cellular constituents of the TME [79,81].”
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 2×
“This transition imparts enhanced migratory and invasive capacity, survival advantage under stress, and increased resistance to apoptotic stimuli [39,131–133].”
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 1×
“Importantly, this crosstalk is bidirectional: while tumor cells reshape the microenvironment to support growth and metastasis, stromal and ECM elements also exert selective pressures that drive tumor adaptation and evolution [24–26].”
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 1×
“In vivo, this dormancy is typically overcome through angiogenesis, during which newly formed blood vessels introduce shear forces that sustain endothelial sprouts and support the delivery of therapeutic agents [49,222].”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 2×
“Once within the TME, macrophages display remarkable phenotypic plasticity [67,68].”
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“There is now a growing appreciation for the need to target both tumor cells and their supportive microenvironment [22,23].”
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 1×
“Factors such as epithelial-to-mesenchymal transition (EMT), oncogene activation, metabolic reprogramming, and altered expression of growth factor receptors can modulate how tumor cells perceive and respond to fibroblast-derived cues [28,31,32].”
Alley, M. C., Scudiero, D. A., Monks, A. P., Hursey, M. L., Czerwiński, M., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., & Boyd, M. R. (1988) · PubMed · Cited by 3,567
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559 · cited 1×
“This neovascularization represents a rate-limiting step in tumor progression [47].”
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427 · cited 2×
“Under hypoxic conditions, central tumor cells rely heavily on anaerobic metabolism, resulting in the accumulation of lactic acid and carbonic acid, which collectively reduce the extracellular pH [107,108].”
InfluentialThe extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024 · cited 4×
“This biochemical framework imparts key biophysical properties to the tumor tissue, including stiffness, porosity, insolubility, and molecular density [5,77–79].”
InfluentialSpatially resolved, highly multiplexed RNA profiling in single cells
Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S., & Zhuang, X. (2015) · Science · doi:10.1126/science.aaa6090 · Cited by 2,969 · cited 1×
“Integrating such spatial omics approaches into spheroid analysis enables a more nuanced understanding of microenvironment-driven cellular states and can uncover emergent regulatory networks missed by bulk RNA-seq [201–203].”
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 5×
“Similarly, agents like paclitaxel, which preferentially target rapidly dividing cells, exhibit reduced cytotoxicity in the low-proliferation zones of tumor cores [99,113].”
InfluentialAnderson, N. M., & Simon, M. C. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.081 · Cited by 2,718
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620 · cited 1×
“Monolayer systems offer several advantages, including simplicity, high-throughput capability, reproducibility, and ease of interpretation [166,167].”
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515 · cited 2×
“These differences are driven by both spatial and mechanical constraints inherent to 3D architecture [191].”
Drug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463 · cited 1×
“CSCs, in particular, exhibit intrinsic resistance to chemotherapy via overexpression of ATP-binding cassette (ABC) drug transporters, enhanced DNA repair capabilities, upregulation of anti-apoptotic proteins, and altered expression of drug metabolism-associated markers [122–124].”
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376 · cited 1×
“This surrounding landscape—referred to as the tumor microenvironment (TME)—comprises a complex network of cellular, acellular, and immune components [5,20,21].”
Benya, P. D., & Shaffer, J. D. (1982) · Cell · doi:10.1016/0092-8674(82)90027-7 · Cited by 2,284 · cited 1×
“In addition to microenvironmental gradients, cells cultured in three-dimensional arrangements exhibit notable differences in morphology and physiology compared to cells grown in monolayers [188–190].”
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279 · cited 1×
“Adipocytes constitute a significant stromal component in the TME of several malignancies, including breast, ovarian, and colorectal cancers [57,58].”
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219 · cited 2×
“The uncoordinated expansion of tumor cells physically displaces adjacent blood and lymphatic vessels, further impairing vascular function and exacerbating hypoxia [105].”
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 4×
“Similarly, agents like paclitaxel, which preferentially target rapidly dividing cells, exhibit reduced cytotoxicity in the low-proliferation zones of tumor cores [99,113].”
InfluentialEGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004 · cited 1×
“Membrane and cytoplasmic proteins like EGFR, HER2, and β -catenin are also commonly evaluated to assess pathway activation, receptor internalization, or EMT transitions [239].”
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T., & Weaver, V. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2544 · Cited by 1,940 · cited 1×
“For example, ECM remodeling can promote asymmetric division in cancer stem cells, disrupt tissue polarity, or facilitate directional migration during invasion [79,82].”
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923 · cited 2×
“…(1) clonal evolution, where genetic and epigenetic changes in initially homogenous tumor cells give rise to distinct subclones over time, and (2) the presence of cancer stem cells (CSCs) from the outset, which generate hierarchically organized progenies with varied phenotypes [119–121].”
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857 · cited 2×
“There is now a growing appreciation for the need to target both tumor cells and their supportive microenvironment [22,23].”
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804 · cited 1×
“The extracellular matrix (ECM), a non-cellular component of the TME, is a highly dynamic and structurally complex scaffold that plays a critical role in regulating tumor progression and therapeutic response [72–74].”
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784 · cited 5×
“With the advancement of tumor biology, it became clear that tumor cells actively re-program surrounding fibroblasts into a modified state termed cancer-associated fibroblasts (CAFs) [5,19,35,36].”
InfluentialDeconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760 · cited 1×
“These missing cues are known to regulate gene expression, drug responsiveness, and apoptotic resistance [172,174,175].”
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674 · cited 1×
“By mimicking the hierarchical structure, proliferation gradients, and stromal interactions found in native tumor tissues, spheroids provide a more physiologically relevant context for evaluating anticancer agents and delivery systems [16,17].”
Isolation of a tumor factor responsible for angiogenesis
Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663 · cited 1×
“As the tumor expands beyond this size, the limited diffusion capacity results in the formation of hypoxic regions, which drive tumor dormancy [50,51].”
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653 · cited 1×
“Importantly, this crosstalk is bidirectional: while tumor cells reshape the microenvironment to support growth and metastasis, stromal and ECM elements also exert selective pressures that drive tumor adaptation and evolution [24–26].”
(1989) · PubMed · Cited by 1,639
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520 · cited 1×
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · cited 2×
“With the advancement of tumor biology, it became clear that tumor cells actively re-program surrounding fibroblasts into a modified state termed cancer-associated fibroblasts (CAFs) [5,19,35,36].”
2D and 3D Cell Cultures - a Comparison of Different Types of Cancer Cell Cultures
Kapałczyńska, M., Kolenda, T., Przybyła, W., Zajączkowska, M., Teresiak, A., Filas, V., Ibbs, M., Bliźniak, R., Łuczewski, Ł., & Lamperska, K. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.63743 · Cited by 1,499 · cited 1×
“These missing cues are known to regulate gene expression, drug responsiveness, and apoptotic resistance [172,174,175].”
The Technology and Biology of Single-Cell RNA Sequencing
Kolodziejczyk, A. A., Kim, J. K., Svensson, V., Marioni, J. C., & Teichmann, S. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.005 · Cited by 1,487
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470 · cited 3×
“These cells mediate tumor suppression through mechanisms such as antigen presentation, secretion of pro-inflammatory cytokines (e.g., interferon-γ , TNF α ), production of ROS, and direct cytotoxic killing of malignant cells [62,63].”
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449 · cited 1×
“…(1) clonal evolution, where genetic and epigenetic changes in initially homogenous tumor cells give rise to distinct subclones over time, and (2) the presence of cancer stem cells (CSCs) from the outset, which generate hierarchically organized progenies with varied phenotypes [119–121].”
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391 · cited 1×
“These metabolites are shuttled to adjacent tumor cells and support mitochondrial oxidative phosphorylation, thereby sustaining tumor cell growth and bioenergetic demands [42–45].”
Three-dimensional cell culture: the missing link in drug discovery
Breslin, S., & O’Driscoll, L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.003 · Cited by 1,332 · cited 1×
“While these models are convenient and scalable, they fail to capture essential characteristics such as spatial cell–cell interactions, oxygen and nutrient gradients, and ECM-mediated diffusion resistance—factors that critically influence drug behavior in solid tumors [6,7].”
Campagnola, P. J., & Loew, L. M. (2003) · Nature Biotechnology · doi:10.1038/nbt894 · Cited by 1,326 · cited 1×
“More recently, second harmonic generation (SHG) microscopy has emerged as a label-free imaging modality capable of visualizing collagen-rich structures within intact spheroids [259,260].”
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265 · cited 1×
“In normal physiology, fibroblasts are essential for maintaining tissue integrity and play pivotal roles in inflammation, wound healing, and fibrosis [29].”
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172 · cited 3×
“These gradients typically emerge when spheroids exceed ~500 µ m in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171 · cited 1×
“Both models contribute to drug resistance through different but overlapping mechanisms [119,120].”
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144 · cited 1×
“Commercial kits, such as CellTiter-Glo ® 3D and Cultrex ® 3D viability assays, are designed to enhance lysis efficiency and signal uniformity in spheroids [15,307].”
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142 · cited 1×
“Consequently, reduced drug penetration necessitates higher dosing, which may contribute to acquired resistance through adaptive cellular mechanisms, such as increased efflux pump expression and impaired apoptotic responses [148].”
(1996) · PubMed · Cited by 1,141
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion
Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y. Y., Meulle, A., Salles, B., Le Gonidec, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3323 · Cited by 1,134
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104 · cited 1×
“Proteolytic fragments of collagen types IV and XVIII—such as endostatin, canstatin, arresten, and tumstatin—modulate the activity of pro-and anti-angiogenic factors, including VEGF, thereby influencing endothelial cell behavior and guiding neovascular sprouting [85].”
Role of Extracellular Matrix in Development and Cancer Progression
Walker, C., Mojares, E., & Del Río Hernández, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,084 · cited 1×
“The ECM is composed of a variety of cross-linked protein macromolecules—including collagen, fibronectin, laminin, and hyaluronan—synthesized primarily by CAFs and tumor cells [75,76].”
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044 · cited 1×
“In contrast to normal tissue, in which lymphatic vessels maintain fluid balance and facilitate macromolecule clearance, tumors exhibit deficient lymphatic drainage, leading to elevated IFP [149,150].”
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032 · cited 1×
“Such plasticity has been observed in multiple carcinoma and melanoma models, where EMT-generated intermediates exhibit stem-like properties, contribute to immune escape, and display altered responsiveness to conventional therapies [136,137].”
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
Lu, W., & Kang, Y. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.010 · Cited by 1,030
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024 · cited 2×
“Commercial kits, such as CellTiter-Glo ® 3D and Cultrex ® 3D viability assays, are designed to enhance lysis efficiency and signal uniformity in spheroids [15,307].”
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994 · cited 1×
“Their survival and resistance characteristics are reinforced by neighboring non-CSC tumor cells that help maintain a specialized microenvironment or “stem cell niche” [126,127].”
Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure
Chen, X., Nadiarynkh, O., Plotnikov, S., & Campagnola, P. J. (2012) · Nature Protocols · doi:10.1038/nprot.2012.009 · Cited by 985 · cited 2×
“SHG leverages the non-centrosymmetric nature of fibrillar collagens to generate signal without the need for fluorescent tags, enabling deep-tissue imaging with minimal photodamage [259,261].”
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929 · cited 4×
“For instance, the efficacy of chemotherapeutic agents that function through oxygen-dependent ROS generation—such as doxorubicin, cisplatin, and imexon—is markedly diminished in hypoxic regions due to insufficient oxygen availability [109–112].”
InfluentialThree-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919 · cited 2×
“These gradients typically emerge when spheroids exceed ~500 µ m in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892 · cited 2×
“Bidirectional communication between tumor cells and the stroma triggers protective signaling cascades, contributing to what is termed Environment-Mediated Drug Resistance (EMDR) [143].”
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866 · cited 1×
“The movement of macromolecules from the plasma into the tumor interstitium is dictated by gradients in hydrostatic and oncotic pressure [151].”
Role of the extracellular matrix in regulating stem cell fate
Watt, F. M., & Huck, W. T. S. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3620 · Cited by 861 · cited 1×
“Tumors can actively regulate ECM stiffness in response to metabolic and mechanical demands [147].”
Elosegui-Artola, A., Oria, R., Chen, Y., Kosmalska, A., Pérez-González, C., Castro, N., Zhu, C., Trepat, X., & Roca-Cusachs, P. (2016) · Nature Cell Biology · doi:10.1038/ncb3336 · Cited by 858
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
IMAMURA, Y., MUKOHARA, T., SHIMONO, Y., FUNAKOSHI, Y., CHAYAHARA, N., TOYODA, M., KIYOTA, N., TAKAO, S., KONO, S., NAKATSURA, T., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3767 · Cited by 845 · cited 1×
“Numerous anticancer compounds that demonstrate robust activity in monolayer cultures fail to reproduce such outcomes in vivo [168–171].”
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793 · cited 1×
“In a separate study, chemoresistance in mammary tumor cells was shown to arise through integrin-mediated cell–ECM interactions that maintained polarity and suppressed apoptosis, underscoring the importance of ECM cues in drug response [177].”
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773 · cited 1×
“Thus, the fibroblast–tumor cell interaction is not only context-dependent but also bidirectionally shaped by the evolving molecular and functional landscape of the tumor itself [33,34].”
Tumor-associated stromal cells as key contributors to the tumor microenvironment
Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0740-2 · Cited by 746 · cited 1×
“Multicellular tumor spheroids are appropriate systems for modeling tumor heterogeneity and microenvironmental complexity [204–206].”
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Stromal myofibroblasts are drivers of invasive cancer growth
De Wever, O., Demetter, P., Mareel, M., & Bracke, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23925 · Cited by 722
Bremnes, R. M., Dønnem, T., Al-Saad, S., Al-Shibli, K., Andersen, S., Sirera, R., Camps, C., Marinez, I., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f8a1bd · Cited by 691 · cited 1×
“While stroma in normal tissues may possess anti-tumor properties, tumor-associated stroma—comprising cancer-associated fibroblasts, ECM, endothelial cells, and immune cells—actively facilitates tumor initiation, invasion, and therapeutic resistance [139–142].”
Drug-induced oxidative stress and toxicity
Deavall, D. G., Martin, E. A., Horner, J. M., & Roberts, R. (2012) · Journal of Toxicology · doi:10.1155/2012/645460 · Cited by 689
The extracellular matrix in tumor progression and metastasis
Eble, J. A., & Niland, S. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09966-1 · Cited by 613 · cited 1×
“These characteristics serve as biomechanical cues that modulate diverse cellular processes, such as migration, proliferation, polarity maintenance, and lineage specification [25,80].”
Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis
Ivascu, A., & Kubbies, M. (2006) · SLAS Discovery · doi:10.1177/1087057106292763 · Cited by 597 · cited 1×
“Basement membrane extracts, such as Matrigel, have also been shown to enhance the structural integrity of spheroids [211].”
Malignant cells facilitate lung metastasis by bringing their own soil
Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016234107 · Cited by 594 · cited 2×
“In a preclinical model of tumor progression, the presence of fibroblasts enhanced the survival of circulating tumor cells, facilitating their colonization at distant sites following primary tumor dissemination [41].”
Perforin-mediated target-cell death and immune homeostasis
Voskoboinik, I., Smyth, M. J., & Trapani, J. A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1983 · Cited by 592 · cited 1×
“These cells mediate tumor suppression through mechanisms such as antigen presentation, secretion of pro-inflammatory cytokines (e.g., interferon-γ , TNF α ), production of ROS, and direct cytotoxic killing of malignant cells [62,63].”
A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone
Bersini, S., Jeon, J. S., Dubini, G., Arrigoni, C., Chung, S., Charest, J. L., Moretti, M., & Kamm, R. D. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.050 · Cited by 534
Lee, J. H., Daugharthy, E. R., Scheiman, J., Kalhor, R., Ferrante, T. C., Terry, R., Turczyk, B. M., Yang, J. L., Lee, H. S., Aach, J., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2014.191 · Cited by 529 · cited 2×
“Emerging spatial transcriptomics platforms, such as MERSCOPE (Vizgen), FISSEQ, ExSeq, Slide-seq, and 10x Genomics Visium, now allow for high-resolution, multiplexed mapping of RNA molecules within intact 3D cultures [199–201].”
High drug attrition rates—where are we going wrong?
Hutchinson, L., & Kirk, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.34 · Cited by 517
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499 · cited 1×
“With the advancement of tumor biology, it became clear that tumor cells actively re-program surrounding fibroblasts into a modified state termed cancer-associated fibroblasts (CAFs) [5,19,35,36].”
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499 · cited 1×
“The three-dimensional (3D) architecture of solid tumors presents significant challenges to the effective penetration and distribution of therapeutic agents [99,100].”
Role of EMT in Metastasis and Therapy Resistance
Smith, B., & Bhowmick, N. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020017 · Cited by 484 · cited 1×
“Factors such as epithelial-to-mesenchymal transition (EMT), oncogene activation, metabolic reprogramming, and altered expression of growth factor receptors can modulate how tumor cells perceive and respond to fibroblast-derived cues [28,31,32].”
Hypoxia Regulates Macrophage Functions in Inflammation
Murdoch, C., Muthana, M., & Lewis, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6257 · Cited by 455
Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction
Dupont, S. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.034 · Cited by 449 · cited 1×
“The matrix not only supports spheroid assembly but also imposes physical constraints that activate intracellular signaling cascades, including MAPK, PI3K/Akt, and YAP/TAZ pathways [214–216].”
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446 · cited 1×
“The ECM is composed of a variety of cross-linked protein macromolecules—including collagen, fibronectin, laminin, and hyaluronan—synthesized primarily by CAFs and tumor cells [75,76].”
Dissecting cancer through mathematics: From the cell to the animal model
Byrne, H. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2808 · Cited by 442 · cited 1×
“This plateau reflects the onset of metabolic stress and reduced proliferative capacity, closely mirroring the dormancy observed in early-stage solid tumors [48,182,221].”
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440 · cited 2×
“While these models are convenient and scalable, they fail to capture essential characteristics such as spatial cell–cell interactions, oxygen and nutrient gradients, and ECM-mediated diffusion resistance—factors that critically influence drug behavior in solid tumors [6,7].”
Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro
Baharvand, H., Hashemi, S. M., Kazemi Ashtiani, S., & Farrokhi, A. (2006) · The International Journal of Developmental Biology · doi:10.1387/ijdb.052072hb · Cited by 429 · cited 1×
“In addition to microenvironmental gradients, cells cultured in three-dimensional arrangements exhibit notable differences in morphology and physiology compared to cells grown in monolayers [188–190].”
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428 · cited 2×
“Conventional viability assays, such as MTT and MTS, which rely on the enzymatic reduction of tetrazolium salts to formazan by metabolically active cells, are commonly used in monolayer systems but require optimization for three-dimensional cultures due to diffusion limitations [306].”
Dudley, A. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006536 · Cited by 424 · cited 3×
“The newly formed vasculature supports continued tumor proliferation by restoring oxygen and nutrient supply and also facilitates metastasis through enhanced intravasation of tumor cells into the circulation [53,54].”
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems
Alon, S., Goodwin, D. R., Sinha, A., Wassie, A. T., Chen, F., Daugharthy, E. R., Bando, Y., Kajita, A., Xue, A. G., Marrett, K., et al. (2021) · Science · doi:10.1126/science.aax2656 · Cited by 419
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
3D tumour models: novel in vitro approaches to cancer studies
Nyga, A., Cheema, U., & Loizidou, M. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0132-4 · Cited by 407 · cited 1×
“This is followed by vascular sprouting and lumen formation, collectively resulting in the generation of a new, albeit abnormal, vascular network within the tumor [49,52].”
Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy
Mai, Z., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06697-4 · Cited by 398 · cited 1×
“However, beyond acting as a physical barrier, ECM stiffness also triggers mechanotransduction pathways that profoundly influence tumor cell behavior [91,92].”
Hypoxia and the Tumor Microenvironment
Li, Y., Zhao, L., & Li, X.-F. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211036304 · Cited by 394 · cited 1×
“This spatial limitation is primarily attributed to architectural and vascular irregularities that create steep gradients in oxygen, nutrient availability, and pH [102].”
RAP2 mediates mechanoresponses of the Hippo pathway
Meng, Z., Qiu, Y., Lin, K. C., Kumar, A., Placone, J. K., Fang, C., Wang, K.-C., Lu, S., Pan, M., Hong, A. W., et al. (2018) · Nature · doi:10.1038/s41586-018-0444-0 · Cited by 377
Mathematical modelling of avascular-tumour growth
Ward, J. (1997) · Mathematical Medicine and Biology · doi:10.1093/imammb/14.1.39 · Cited by 375 · cited 2×
“This plateau reflects the onset of metabolic stress and reduced proliferative capacity, closely mirroring the dormancy observed in early-stage solid tumors [48,182,221].”
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics
Prakash, J., & Shaked, Y. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0002 · Cited by 366
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362 · cited 1×
“Because a significant number of anti-cancer drugs (e.g., melphalan, busulfan, carboplatin, and cisplatin) are weak bases, their increased ionization under acidic conditions limits their transmembrane diffusion and cellular uptake, ultimately reducing therapeutic efficacy [117,118].”
Control of cellular responses to mechanical cues through YAP/TAZ regulation
Dasgupta, I., & McCollum, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007963 · Cited by 360 · cited 2×
“These signals modulate gene expression profiles associated with proliferation, EMT, and drug resistance [95,96].”
Härmä, V., Virtanen, J., Mäkelä, R., Happonen, A., Mpindi, J.-P., Knuuttila, M., Kohonen, P., Lötjönen, J., Kallioniemi, O., & Nees, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010431 · Cited by 344
The Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343 · cited 1×
“Thus, TAMs serve as both immunological suppressors and facilitators of malignant progression [70,71].”
Luca, A. C., Mersch, S., Deenen, R., Schmidt, S., Messner, I., Schäfer, K.-L., Baldus, S. E., Huckenbeck, W., Piekorz, R. P., Knoefel, W. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059689 · Cited by 341
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Zhou, J., Nefedova, Y., Lei, A., & Gabrilovich, D. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.004 · Cited by 339 · cited 1×
“Conversely, pro-tumor immune populations—such as regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and M2-polarized macrophages—are involved in suppressing immune surveillance, promoting angiogenesis, and facilitating metastasis [62,64,65].”
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338 · cited 2×
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
What's wrong with our cancer models?
Kamb, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1635 · Cited by 335 · cited 1×
“Together, this disconnect between conventional monolayer models and the complexity of the in vivo tumor environment contributes to the high rate of failure observed during the transition from preclinical studies to clinical development [11–13].”
Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
Brassart-Pasco, S., Brézillon, S., Brassart, B., Ramont, L., Oudart, J.-B., & Monboisse, J. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00397 · Cited by 335 · cited 1×
“In advanced tumors, excessive ECM deposition leads to mechanical compression of adjacent blood and lymphatic vessels, resulting in elevated interstitial fluid pressure (IFP) [87].”
Nelson, C. M., & Bissell, M. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.001 · Cited by 332
The Role of Macrophages in Cancer Development and Therapy
Cendrowicz, E., Sas, Z., Bremer, E., & Rygiel, T. P. (2021) · Cancers · doi:10.3390/cancers13081946 · Cited by 332 · cited 1×
“Thus, TAMs serve as both immunological suppressors and facilitators of malignant progression [70,71].”
Tumour-on-a-chip provides an optical window into nanoparticle tissue transport
Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V., & Chan, W. C. W. (2013) · Nature Communications · doi:10.1038/ncomms3718 · Cited by 330 · cited 4×
“Nanoparticles of varying sizes were introduced into the flow channel, and their transport was found to be size-dependent, with smaller particles penetrating more deeply into the spheroid [230].”
InfluentialMicroenvironmental regulation of cancer development
Hu, M., & Polyak, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.006 · Cited by 330
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
Teicher, B., Herman, T., Holden, S., Wang, Y., Pfeffer, M., Crawford, J., & Frei, E. (1990) · Science · doi:10.1126/science.247.4949.1457 · Cited by 327 · cited 1×
“…have demonstrated that tumors exposed to repeated alkylating agent treatment in murine models developed significant resistance, which was not observed when the same cells were cultured in vitro, underscoring the essential role of stromal interactions in modulating therapeutic response [146].”
Ghosh, S., Spagnoli, G. C., Martin, I., Ploegert, S., Demougin, P., Heberer, M., & Reschner, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20320 · Cited by 326 · cited 3×
“In one comparative study, transcriptomic analysis of melanoma cells cultured as monolayers, monolayers with ECM, and spheroids revealed that gene expression remained largely unchanged between the two monolayer conditions, while spheroid cultures exhibited substantial differences [194,195].”
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323 · cited 2×
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320 · cited 3×
“Earlier theories of tumor biology proposed that tumor initiation results from genetic alterations within a single cell [18,19].”
Two-photon excitation microscopy for the study of living cells and tissues
Benninger, R. K. P., & Piston, D. W. (2013) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0411s59 · Cited by 311 · cited 1×
“These constraints can reduce imaging accuracy, particularly in larger or more optically opaque spheroids [296].”
Chang, T. T., & Hughes-Fulford, M. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2007.0434 · Cited by 311 · cited 1×
“A similar trend was observed in hepatocellular carcinoma models, where monolayers showed enrichment in structural gene expression, whereas spheroids upregulated genes related to metabolism and biosynthesis [196–198].”
(2000) · PubMed · Cited by 295
One mouse, one patient paradigm: New avatars of personalized cancer therapy
Malaney, P., Nicosia, S. V., & Davé, V. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.010 · Cited by 289 · cited 2×
“However, these models are expensive to establish and maintain, and they raise questions regarding tumor stage at engraftment—whether during early growth or after multiple mutations and metastatic progression—which directly influences therapeutic outcomes [180].”
The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate
(2018) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.002 · Cited by 286
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285 · cited 4×
“Regulatory guidelines necessitate testing in both rodent and non-rodent species prior to clinical trials, with murine models favored for their low cost, rapid breeding, and amenability to genetic modification [178,179].”
InfluentialGenetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 282 · cited 1×
“As a result, intracellular signaling pathways and gene expression profiles are substantially modified [191,192].”
Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10172-z · Cited by 281
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Fang, Z., Meng, Q., Xu, J., Wang, W., Zhang, B., Liu, J., Liang, C., Hua, J., Zhao, Y., Yu, X., et al. (2023) · Cancer Communications · doi:10.1002/cac2.12392 · Cited by 280 · cited 1×
“Thus, the fibroblast–tumor cell interaction is not only context-dependent but also bidirectionally shaped by the evolving molecular and functional landscape of the tumor itself [33,34].”
Microfluidic platforms for mechanobiology
Polacheck, W. J., Li, R., Uzel, S. G. M., & Kamm, R. D. (2013) · Lab on a Chip · doi:10.1039/c3lc41393d · Cited by 272 · cited 1×
“These systems enable continuous delivery of oxygen, nutrients, and therapeutic agents while introducing shear stress and directional mass transport, thereby allowing the investigation of flow-regulated processes within a tumor-relevant architecture [224–228].”
Lazzari, G., Nicolas, V., Matsusaki, M., Akashi, M., Couvreur, P., & Mura, S. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.008 · Cited by 271 · cited 2×
“Spheroids also exhibit significantly higher levels of ECM deposition compared to monolayer cultures, particularly when stromal components are present [209,210].”
Extracellular matrix stiffness: Mechanisms in tumor progression and therapeutic potential in cancer
Zhang, M., & Zhang, B. (2025) · Experimental Hematology & Oncology · doi:10.1186/s40164-025-00647-2 · Cited by 269 · cited 2×
“In these settings, increased stiffness not only impedes drug penetration but also fosters an aggressive tumor phenotype and enhances resistance to chemotherapeutic agents [92,98].”
(1992) · PubMed · Cited by 247
Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids
Tchoryk, A., Taresco, V., Argent, R. H., Ashford, M., Gellert, P. R., Stolnik, S., Grabowska, A., & Garnett, M. C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00136 · Cited by 243 · cited 1×
“When coupled with fluorescently labeled therapeutic agents, these gradients can be visualized as bivariate fluorescence distributions, providing insights into relative penetration and uptake across different formulations [300].”
McIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239 · cited 2×
“In contrast, cells located in the intermediate zone are often senescent, while those in the central core exist in a hypoxic state [101,184,186,187].”
Endothelial-cell proliferation in experimental tumours
Denekamp, J., & Hobson, B. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.263 · Cited by 237 · cited 1×
“These arise due to the disparity between the rapid proliferation of tumor cells and the slower proliferation and disorganized arrangement of endothelial cells responsible for vascularization [103,104].”
Yu, M., Qi, B., Xiaoxiang, W., Xu, J., & Liu, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.001 · Cited by 234
Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation
Jaganathan, H., Gage, J., Leonard, F., Srinivasan, S., Souza, G. R., Dave, B., & Godin, B. (2014) · Scientific Reports · doi:10.1038/srep06468 · Cited by 231 · cited 1×
“In breast tumor models, spheroids generated with higher fibroblast content exhibited decreased diffusion of dextran dye and diminished cytotoxicity following doxorubicin exposure [208].”
Extracellular Matrix, a Hard Player in Angiogenesis
Mongiat, M., Andreuzzi, E., Tarticchio, G., & Paulitti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111822 · Cited by 223 · cited 1×
“In addition to its structural and signaling roles, the ECM actively contributes to tumor angiogenesis [83,84].”
Amaral, R. L. F., Miranda, M., Marcato, P. D., & Swiech, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00605 · Cited by 222 · cited 1×
“To mitigate this, spheroids are often cultured in ultra-low attachment plates or transferred to clean imaging wells prior to measurement to ensure consistent visualization [304,305].”
Konerding, M. A., Malkusch, W., Klapthor, B., Ackern, C. V., Fait, E., Hill, S. A., Parkins, C., Chaplin, D. J., Presta, M., & Denekamp, J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690416 · Cited by 221 · cited 1×
“They display irregular diameters, lack the hierarchical architecture typical of the arterial-arteriolar-capillary network, and exhibit increased permeability and fragility [55,56].”
(1991) · PubMed · Cited by 220
Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., & Kerbel, R. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6028 · Cited by 217 · cited 4×
“Among the various stromal cells within the TME, fibroblasts constitute the dominant cellular mass [27–30].”
InfluentialTumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212 · cited 1×
“This transition imparts enhanced migratory and invasive capacity, survival advantage under stress, and increased resistance to apoptotic stimuli [39,131–133].”
Reed, R. K., & Rubin, K. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq143 · Cited by 209 · cited 1×
“This elevated IFP diminishes convective transport, reduces vascular perfusion, and severely impairs drug accumulation in the tumor core [88,89].”
Akl, M. R., Nagpal, P., Ayoub, N. M., Tai, B., Prabhu, S. A., Capac, C. M., Gliksman, M., Goy, A., & Suh, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.8203 · Cited by 209 · cited 1×
“This behavior is consistent with the known paracrine interactions in which fibroblasts secrete pro-angiogenic factors such as VEGF and Fibroblast Growth Factor 2 (FGF2), which facilitate endothelial cell growth and organization [283,284].”
3D tumor models: History, advances and future perspectives
Benien, P., & Swami, A. (2014) · Future Oncology · doi:10.2217/fon.13.274 · Cited by 208 · cited 5×
“These interactions are absent in monolayers but are necessary for recapitulating drug responses observed in vivo [101,186].”
InfluentialSecond harmonic generation microscopy: a powerful tool for bio-imaging
Aghigh, A., Bancelin, S., Rivard, M., Pinsard, M., Ibrahim, H., & Légaré, F. (2023) · Biophysical Reviews · doi:10.1007/s12551-022-01041-6 · Cited by 207 · cited 2×
“SHG leverages the non-centrosymmetric nature of fibrillar collagens to generate signal without the need for fluorescent tags, enabling deep-tissue imaging with minimal photodamage [259,261].”
Lisanti, M. P., Martinez-Outschoorn, U. E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A. K., Lin, Z., Balliet, R. M., Howell, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13370 · Cited by 199 · cited 2×
“These metabolites are shuttled to adjacent tumor cells and support mitochondrial oxidative phosphorylation, thereby sustaining tumor cell growth and bioenergetic demands [42–45].”
Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-41 · Cited by 197 · cited 1×
“In addition to hypoxia, fibroblasts respond to a variety of chemotactic signals such as TGF-β , PDGF, and CXCL12, which are differentially distributed within tumors and further drive their directed migration toward tumor cores [286].”
Khaitan, D., Chandna, S., Arya, M., & Dwarakanath, B. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-12 · Cited by 196
Mechanisms of anti-cancer agents: Emphasis on oxidative stress and electron transfer
Kovacic, P., & Osuna Jr., J. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003401046 · Cited by 187 · cited 1×
“For instance, the efficacy of chemotherapeutic agents that function through oxygen-dependent ROS generation—such as doxorubicin, cisplatin, and imexon—is markedly diminished in hypoxic regions due to insufficient oxygen availability [109–112].”
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Ma, H.-L., Jiang, Q., Han, S., Wu, Y., Tomshine, J. C., Wang, D., Gan, Y., Zou, G., & Liang, X.-J. (2012) · Molecular Imaging · doi:10.2310/7290.2012.00012 · Cited by 182 · cited 1×
“A range of microscopic techniques has been employed to evaluate spheroid growth, morphology, and internal cellular organization [14,182,232].”
Karlsson, H., Fryknäs, M., Larsson, R., & Nygren, P. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.026 · Cited by 180 · cited 1×
“Monolayer systems offer several advantages, including simplicity, high-throughput capability, reproducibility, and ease of interpretation [166,167].”
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Hompland, T., Fjeldbo, C. S., & Lyng, H. (2021) · Cancers · doi:10.3390/cancers13030499 · Cited by 179 · cited 1×
“These central regions are poorly perfused and metabolically stressed, whereas peripheral tumor cells—being in closer proximity to functional vasculature—exhibit higher proliferative indices [106].”
Ricketts, T. D., Prieto-Dominguez, N., Gowda, P. S., & Ubil, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642285 · Cited by 179 · cited 2×
“Once within the TME, macrophages display remarkable phenotypic plasticity [67,68].”
Three-Dimensional Culture of Human Breast Epithelial Cells: The How and the Why
Vidi, P.-A., Bissell, M. J., & Lelièvre, S. A. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-125-7_13 · Cited by 178 · cited 2×
“Penetration depth can be quantified by imaging serial sections of the spheroid or by generating optical Z-stacks with confocal microscopy [246,247].”
pH distribution in human tumors
Thistlethwaite, A. J., Leeper, D. B., Moylan, D. J., & Nerlinger, R. E. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90217-2 · Cited by 177
Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer
Nurwidya, F., Takahashi, F., Murakami, A., & Takahashi, K. (2012) · Cancer Research and Treatment · doi:10.4143/crt.2012.44.3.151 · Cited by 177
Elgundi, Z., Papanicolaou, M., Major, G., Cox, T. R., Melrose, J., Whitelock, J. M., & Farrugia, B. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01482 · Cited by 176 · cited 1×
“These characteristics serve as biomechanical cues that modulate diverse cellular processes, such as migration, proliferation, polarity maintenance, and lineage specification [25,80].”
(1972) · PubMed · Cited by 172
Agarwal, R., Jurney, P., Raythatha, M., Singh, V., Sreenivasan, S. V., Shi, L., & Roy, K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500441 · Cited by 169 · cited 1×
“…of the drug or particle—including size, surface charge, shape, lipophilicity, and acid dissociation constant—as well as by the structural and biochemical properties of the spheroid, such as ECM density, extracellular pH gradients, and compactness of the cellular arrangement [99,206,290].”
Vörsmann, H., Groeber, F., Walles, H., Busch, S., Beissert, S., Walczak, H., & Kulms, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.249 · Cited by 168 · cited 1×
“In melanoma spheroids, for example, fibroblasts have been shown to accumulate in low-oxygen regions and upregulate genes associated with ECM production and wound response [288].”
A unique role for p53 in the regulation of M2 macrophage polarization
Li, L., Ng, D. S. W., Mah, W.-C., Almeida, F. F., Rahmat, S. A., Rao, V. K., Leow, S. C., Laudisi, F., Peh, M. T., Goh, A. M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.212 · Cited by 168 · cited 1×
“This polarization is stimulus-dependent: classically activated (M1) macrophages adopt a pro-inflammatory, anti-tumor phenotype, while alternatively activated (M2) macrophages acquire an immunosuppressive, pro-tumor phenotype [40,69].”
Biomedical Tissue Research, D. O. B. (. 9., Saleh, F., Whyte, M., & Genever, P. (2011) · European Cells and Materials · doi:10.22203/ecm.v022a19 · Cited by 160 · cited 1×
“The spatial proximity of HUVECs to HLFs supports the idea of stromal-guided endothelial localization and provides further evidence of biologically relevant cell–cell interactions within these 3D systems [285].”
Unger, C., Kramer, N., Walzl, A., Scherzer, M., Hengstschläger, M., & Dolznig, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.015 · Cited by 158 · cited 1×
“This replacement compromises the tumor–stroma interactions that are essential for evaluating the therapeutic response in a human-like microenvironment [179,181].”
The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Boussommier-Calleja, A., Atiyas, Y., Haase, K., Headley, M., Lewis, C., & Kamm, R. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.005 · Cited by 158
Physical and chemical mechanisms of tissue optical clearing
Yu, T., Zhu, J., Li, D., & Zhu, D. Y. (2021) · iScience · doi:10.1016/j.isci.2021.102178 · Cited by 158 · cited 1×
“To overcome this, spheroid clearing methods—such as lipid removal using chemical agents—have been developed to enhance light penetration by reducing refractive index mismatches and optical opacity [250–252].”
The nutrient environment affects therapy
Muir, A., & Vander Heiden, M. G. (2018) · Science · doi:10.1126/science.aar5986 · Cited by 157 · cited 1×
“Cells grown on flat plastic surfaces have unrestricted access to nutrients, oxygen, and therapeutic agents, unlike tumor cells in vivo that experience diffusion limitations due to disorganized vasculature and spatial gradients [172,173].”
Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models
Costa, E. C., Gaspar, V. M., Coutinho, P., & Correia, I. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25210 · Cited by 156 · cited 4×
“By incorporating stromal cell types, such as fibroblasts, endothelial cells, or immune cells, these models more closely replicate the cellular composition of in vivo tumors [182].”
InfluentialMigneco, G., Whitaker-Menezes, D., Chiavarina, B., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Flomenberg, N., Tsirigos, A., Howell, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11989 · Cited by 153 · cited 1×
“Tumor cells induce oxidative stress in adjacent fibroblasts, triggering the production of reactive oxygen species (ROS) [42–44].”
Liao, T., & Yang, M. (2020) · Cells · doi:10.3390/cells9030623 · Cited by 152 · cited 1×
“Notably, EMT is not always binary; tumor cells can exist in hybrid epithelial/mesenchymal states that further diversify the tumor landscape [134,135].”
Treg(s) in Cancer: Friends or Foe?
Wolf, D., Sopper, S., Pircher, A., Gastl, G., & Wolf, A. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25016 · Cited by 151 · cited 1×
“Conversely, pro-tumor immune populations—such as regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and M2-polarized macrophages—are involved in suppressing immune surveillance, promoting angiogenesis, and facilitating metastasis [62,64,65].”
Yao, H.-J., Ju, R.-J., Wang, X., Zhang, Y., Li, R., Yu, Y., Zhang, L., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.038 · Cited by 151 · cited 1×
“Although more resource-intensive, electron microscopy enables detailed visualization of membrane structures, organelle integrity, and ECM [257].”
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Gaggar, S., & Gögenur, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668731 · Cited by 150 · cited 1×
“Among the various stromal cells within the TME, fibroblasts constitute the dominant cellular mass [27–30].”
Baek, S.-K., Makkouk, A. R., Krasieva, T., Sun, C.-H., Madsen, S. J., & Hirschberg, H. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0511-3 · Cited by 149 · cited 1×
“These methods have been particularly useful in capturing dynamic biological processes and resolving complex cellular arrangements within intact spheroids [253–255].”
Aung, A., Kumar, V., Theprungsirikul, J., Davey, S. K., & Varghese, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0342 · Cited by 146 · cited 1×
“Beyond fibroblasts, similar strategies have been used in immune-tumor spheroids to investigate how macrophages or T cells migrate in response to tumor-derived chemokines, influencing immune suppression, matrix remodeling, or drug resistance [289].”
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Mierke, C. T. (2024) · Cells · doi:10.3390/cells13010096 · Cited by 146 · cited 2×
“Beyond serving as a physical barrier, the incorporation of ECM during spheroid formation introduces a biomechanical stimulus that strongly influences cellular phenotype [213].”
Buchanan, C. F., Voigt, E. E., Szot, C. S., Freeman, J. W., Vlachos, P. P., & Rylander, M. N. (2014) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0731 · Cited by 143 · cited 2×
“When exposed to flow, these configurations exhibited increased expression of pro-angiogenic genes, indicating that mechanical forces can regulate angiogenic signaling and alter cellular responses to their environment [223].”
Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids
Riffle, S., Pandey, R. N., Albert, M., & Hegde, R. S. (2017) · BMC Cancer · doi:10.1186/s12885-017-3319-0 · Cited by 142 · cited 1×
“Fluorescently labeled antibodies targeting markers such as caspase-3, Ki-67, and hypoxia-inducible factors, or exogenous hypoxia indicators such as pimonidazole and EF5, allow visualization of apoptotic, proliferating, or hypoxic regions, respectively [235,236].”
Cell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kitaeva, K. V., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00322 · Cited by 142
Hsiao, A. Y., Tung, Y., Qu, X., Patel, L. R., Pienta, K. J., & Takayama, S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24399 · Cited by 137
Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D
Laurent, J., Frongia, C., Cazales, M., Mondesert, O., Ducommun, B., & Lobjois, V. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-73 · Cited by 130 · cited 2×
“Beyond population tracking, assessment of cell cycle status provides further insight into functional heterogeneity within spheroids [267,268].”
The Fluid Mechanics of Cancer and Its Therapy
Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129 · cited 1×
“In contrast to normal tissue, in which lymphatic vessels maintain fluid balance and facilitate macromolecule clearance, tumors exhibit deficient lymphatic drainage, leading to elevated IFP [149,150].”
Biomedical Applications of Tissue Clearing and Three-Dimensional Imaging in Health and Disease
Gómez‐Gaviro, M. V., Sanderson, D., Ripoll, J., & Desco, M. (2020) · iScience · doi:10.1016/j.isci.2020.101432 · Cited by 129
Binding and interstitial penetration of liposomes within avascular tumor spheroids
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W., Ballangrud, Å., & Sgouros, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20457 · Cited by 127 · cited 2×
“Similarly, overall affinity can be inferred by summing the fluorescence intensity across all sections [293].”
Chen, Q., Liu, L., Lu, Y., Chen, X., Zhang, Y., Zhou, W., Guo, Q., Li, C., Zhang, Y., Zhang, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201802134 · Cited by 126 · cited 1×
“The conventional drug screening workflow typically begins with testing compounds on tumor cells cultured as 2D monolayers, followed by evaluation in animal models [163–165].”
Hypoxic Signaling During Tissue Repair and Regenerative Medicine
Nauta, T., Van Hinsbergh, V., & Koolwijk, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119791 · Cited by 123 · cited 1×
“This central accumulation of fibroblasts is consistent with known in vivo behavior, where stromal cells such as fibroblasts migrate toward hypoxic regions to participate in extracellular matrix remodeling and survival signaling [279–282].”
A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems
Chen, Y., Gao, D., Wang, Y., Lin, S., & Jiang, Y. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.06.038 · Cited by 122 · cited 2×
“Recent advances have led to the development of tri-channel systems that structurally model key features of the tumor microenvironment [231].”
The impact of tumor stroma on drug response in breast cancer
Dittmer, J., & Leyh, B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.05.006 · Cited by 120 · cited 2×
“In addition to biochemical crosstalk, the ECM in tumors is often excessively rigid and densely cross-linked, forming a formidable physical barrier that impedes drug diffusion [129].”
Gujam, F. J. A., Edwards, J., Mohammed, Z. M. A., Going, J. J., & McMillan, D. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.279 · Cited by 113 · cited 1×
“The ability to systematically vary the ratio of tumor to stromal cells enables the study of how microenvironmental components influence therapeutic response [207].”
The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer
Yan, Y., Chen, X., Wang, X., Zhao, Z., Hu, W., Zeng, S., Wei, J., Yang, X., Qian, L., Zhou, S., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1172-5 · Cited by 113
Yeon, S.-E., No, D. Y., Lee, S.-H., Nam, S. W., Oh, I.-H., Lee, J., & Kuh, H.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073345 · Cited by 110 · cited 2×
“Two primary strategies are commonly employed to address this [245].”
Research works printed but not linked: 1
- Shah S. Development of co-culture spheroid models of drug-resistant carcinomas for the in vitro testing of anti-tumor treatment strategies Doctor of Philosophy Dissertation MCPHS Boston, USA 2024
Cited by
Madan, A., Saini, R., Dhiman, N., Juan, S., & Satapathy, M. K. (2025) · Organoids · doi:10.3390/organoids4040023 · Cited by 24
“Organoids derived from CSC-enriched populations often demonstrate enhanced tumorigenicity, metastatic potential, and therapeutic resistance, making them ideal models for studying relapse, dormancy, and evolution under drug pressure [36].”
Cancer Metastasis: Therapeutic Challenges and Opportunities
Garemilla, S. S. S., Kadambala, M. C., Gampa, S. C., Chinthala, S., & Garimella, S. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03072-x · Cited by 15
“The bio-physical properties of the TME particularly its dense ECM and elevated interstitial fluid pressure limit uniform drug distribution and reduce therapeutic efficacy, often contributing to treatment failure and recurrence [98].”
Shukla, A. K., Shukla, S., Suryawanshi, S. P., Upadhyay, A. M., Ray, N., Thiruppathi, G., Dutta, S. D., & Mongre, R. K. (2025) · Current Oncology · doi:10.3390/curroncol32120653 · Cited by 10
“By integrating cellular, extracellular, and mechanical cues within a precisely engineered 3D matrix, these models overcome many limitations of conventional two-dimensional cultures, providing more physiologically relevant platforms for studying tumor biology [46,47].”
Mokhles, F., Moosavi, M. A., Gutiérrez-Uzquiza, Á., Velasco, G., Li, M., & Cordani, M. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218246 · Cited by 13
Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection
Azim, M. M. N., Bhajan, S. K., Park, J. H., Abass, K. S., Rahman, A., Choi, M., Choi, J., Park, S., Kim, H. J., Akter, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072954 · Cited by 8
Metadata
- Authors
- Shah, S., & D’Souza, G. G. M.
- Affiliations
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Shah, Shrey
- ORCID
- Shah, Shrey
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-05-17
- Volume
- 14
- Issue
- 10
- Pages
- 732
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12110291
- OpenAlex
- W4410519085
- Cited by
- 83
- References
- 326
- Citations by year
- 2026: 72 · 2025: 11
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor spheroids, tumor microenvironment, solid tumors, drug delivery barriers, extracellular matrix, hypoxia, interstitial fluid pressure, tumor-stroma interactions, 3D tumor models, drug penetration, drug resistance, confocal microscopy, cytotoxicity
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Spheroids, Cellular, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.